Clinical Trials Browser

Recruiting × Triple Negative Breast Neoplasms × spartalizumab × Clear all

NCT06471205 2025-05-07

A Study of BL-B01D1+PD-1 Monoclonal Antibody in Patients With Unresectable Locally Advanced or Recurrent Metastatic Triple-negative Breast Cancer

Phase 2 Recruiting

Triple Negative Breast Neoplasms